Genetic mapping of lung cancer modifier loci specifically affecting tumor initiation and progression

Cancer Research

Volumn 57, Issue 19, 1997, Pages 4164-4166

  Manenti, Giacomo ^a   Gariboldi, Manuela ^a   Fiorino, Antonio ^a   Zanesi, Nicola ^a   Pierotti, Marco A ^a   Dragani, Tommaso A ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SUSCEPTIBILITY; CHROMOSOME 18; FEMALE; GENE LOCATION; GENE LOCUS; GENETIC SUSCEPTIBILITY; LUNG CARCINOGENESIS; LUNG CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOMA; ANIMALS; CHROMOSOME MAPPING; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; FEMALE; LOD SCORE; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; NEOPLASMS, MULTIPLE PRIMARY;

EID: 0030818561     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gariboldi, M., Manenti, G., Canzian, F., Falvella, F. S., Radice, M. T., Pierotti, M. A., Della Porta, G., Binelli, G., and Dragani, T. A. A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6. Nat. Genet., 3: 132-136, 1993.
2. Dragani, T. A., Manenti, G., and Pierotti, M. A. Genetics of murine lung tumors. Adv. Cancer Res., 67: 83-112, 1995.
3. Manenti, G., Gariboldi, M., Elango, R., Fiorino, A., De Gregorio, L., Falvella, F. S., Hunter, K., Housman, D., Pierotti, M. A., and Dragani, T. A. Genetic mapping of a pulmonary adenoma resistance locus (Par1) in mouse. Nat. Genet., 12: 455-457, 1996.
4. Malkinson, A. M., and Beer, D. S. Major effect on susceptibility to urethan-induced pulmonary adenoma by a single gene in BALB/cBy mice. J. Natl. Cancer Inst., 70: 931-936, 1983.
5. Manenti, G., Gariboldi, M., Fiorino, A., Zedda, A. I., Pierotti, M. A., and Dragani, T. A. Pas1 is a common lung cancer susceptibility locus in three mouse strains. Mamm. Genome, in press, 1997.
6. Obata, M., Nishimori, H., Ogawa, K., and Lee, G. H. Identification of the Par2 (pulmonary adenoma resistance) locus on mouse chromosome 18, a major genetic determinant for lung carcinogen resistance in BALB/cByJ mice. Oncogene, 13: 1599-1604, 1996.
7. Dragani, T. A., Manenti, G., and Della Porta, G. Quantitative analysis of genetic susceptibility to liver and lung carcinogenesis in mice. Cancer Res., 51: 6299-6303, 1991.
8. Lander, E. S., Green, P., Abrahamson, J., Barlow, A., Daly, M. J., Lincoln, S. E., and Newburg, L. MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. Genomics, 1: 174-181, 1987.
9. Lander, E. S., and Botstein, D. Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics, 121: 185-199, 1989.
10. Conover, W. J., and Iman, R. L. Rank transformations as a bridge between parametric and nonparametric statistics. Am. Stat., 35: 124-129, 1981.
11. Johnson, K. R., and Davisson, M. T. Mouse chromosome 18. Mamm. Genome, 6: S300-S308, 1996.
12. Pataer, A., Kamoto, T., Lu, L. M., Yamada, Y., and Hiai, H. Two dominant host resistance genes to pre-B lymphoma in wild-derived inbred mouse strain MSM/Ms. Cancer Res., 56; 3716-3720, 1996.
13. Fijneman, R. A., de Vries, S. S., Jansen, R. C., and Demant, P. Complex interactions of new quantitative trait loci. Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat. Genet., 14: 465-470, 1996.
14. Herzog, C. R., Soloff, E. V., McDaniels, A. L., Tyson, F. L., Malkinson, A. M., Haugen-Strano, A., Wiseman, R. W., Anderson, M. W., and You, M. Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-α and p16INK4a-β in mouse lung tumor cells. Oncogene, 13: 1885-1891, 1996.
15. Herzog, C. R., Wang, Y., and You, M. Allelic loss of distal chromosome 4 in mouse lung tumors localize a putative tumor suppressor gene to a region homologous with human chromosome 1p36. Oncogene, 11: 1811-1815, 1995.
16. Tsuchiya, E., Nakamura, Y., Weng, S-Y., Nagakawa, K., Tsuchiya, S., Sugano, H., and Kitagawa, T. Allelotype of non-small cell lung carcinoma: comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res., 52: 2478-2481, 1992.
17. Merlo, A., Gabrielson, E., Askin, F., and Sidransky, D. Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res., 54: 640-642, 1994.
18. de Vos, S., Miller, C. W., Takeuchi, S., Gombart, A. F., Cho, S. K., and Koeffler, H. P. Alterations of CDKN2 (p16) in non-small cell lung cancer. Genes Chromosomes Cancer, 14: 164-170, 1995.
19. Weston, A., Ling-Cawley, H. M., Caporaso, N. E., Bowman, E. D., Hoover, R. N., Trump, B. F., and Harris, C. C. Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. Carcinogenesis (Lond.), 15: 583-587, 1994.
20. Kawashima, K., Nomura, S., Hirai, H., Fukushi, S., Karube, T., Takeuchi, K., Naruke, T., and Nishimura, S. Correlation of L-myc RFLP with metastasis, prognosis and multiple cancer in lung-cancer patients. Int. J. Cancer, 50: 557-561, 1992.
21. Ge, H., Lam, W. K., Lee, J., Wong, M. P., Yew, W. W., and Lung, M. L. Analysis of L-myc and GSTM1 genotypes in Chinese non-small cell lung carcinoma patients. Lung Cancer, 15: 355-366, 1996.
22. Manenti, G., De Gregorio, L., Pilotti, S., Falvella, F. S., Incarbone, M., Ravagnani, F., Pierotti, M. A., and Dragani, T. A. Association of chromosome 12p genetic polymorphisms with lung adenocarcinoma risk and prognosis. Carcinogenesis (Lond.), in press, 1997.
23. Nagase, H., Bryson, S., Cordell, H., Kemp, C. J., Fee, F., and Balmain, A. Distinct genetic loci control development of benign and malignant skin tumours in mice. Nat. Genet., 10: 424-429, 1995.